In breast carcinoma patients, the expression levels of FXR were positively correlated with tumor size and the proliferative rate of tumor cells [107], suggesting FXR as a prognosticator of invasive breast carcinoma. This evidence concerns the gene NR1H4 and breast carcinoma.